Recipharm, a global CDMO, has successfully extended its manufacturing license to include immunology products, allowing the company to provide vaccine products at clinical and commercial scales, in both freeze-dried and liquid forms. The license applies to its facility in Wasserburg, Germany, and also covers microbiological testing allowing Recipharm to insource bacterial endotoxin testing on its products, including testing diluent for one of the COVID-19 vaccines.   Kjell Johansson, Presid...